- Home
- STE vs QSR Comparison
STE vs QSR Comparison
Compare STE & QSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STE
- QSR
- Stock Information
- Founded
- STE 1985
- QSR 1954
- Country
- STE United States
- QSR Canada
- Employees
- STE N/A
- QSR N/A
- Industry
- STE Industrial Specialties
- QSR
- Sector
- STE Health Care
- QSR
- Exchange
- STE Nasdaq
- QSR Nasdaq
- Market Cap
- STE 23.9B
- QSR N/A
- IPO Year
- STE 1992
- QSR 2006
- Fundamental
- Price
- STE $240.63
- QSR $68.92
- Analyst Decision
- STE Buy
- QSR Buy
- Analyst Count
- STE 9
- QSR 19
- Target Price
- STE $261.00
- QSR $77.74
- AVG Volume (30 Days)
- STE 541.4K
- QSR 4.2M
- Earning Date
- STE 08-05-2025
- QSR 08-07-2025
- Dividend Yield
- STE 0.96%
- QSR 3.60%
- EPS Growth
- STE 63.01
- QSR N/A
- EPS
- STE 6.21
- QSR 2.94
- Revenue
- STE $5,459,515,000.00
- QSR $8,776,000,000.00
- Revenue This Year
- STE $7.61
- QSR $9.51
- Revenue Next Year
- STE $6.04
- QSR $3.22
- P/E Ratio
- STE $38.56
- QSR $23.46
- Revenue Growth
- STE 6.24
- QSR 22.38
- 52 Week Low
- STE $200.98
- QSR $58.71
- 52 Week High
- STE $252.79
- QSR $75.07
- Technical
- Relative Strength Index (RSI)
- STE 45.72
- QSR 57.66
- Support Level
- STE $236.73
- QSR $64.44
- Resistance Level
- STE $243.08
- QSR $68.49
- Average True Range (ATR)
- STE 3.64
- QSR 1.09
- MACD
- STE -0.43
- QSR 0.20
- Stochastic Oscillator
- STE 29.72
- QSR 98.68
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.